Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment

INTRODUCTION: Myasthenia gravis (MG) is a devastating acquired autoimmune disease that can seriously affect the patient’s quality of life. It is also a common complication of thymoma. Previous studies have shown that docetaxel alleviates myasthenic symptoms in thymoma with MG (TMG). However, little...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hongxia, Qi, Guoyan, Dong, Huimin, Liu, Ze, Ma, Mei, Liu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043105/
https://www.ncbi.nlm.nih.gov/pubmed/36786935
http://dx.doi.org/10.1007/s40120-023-00442-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043105/
https://www.ncbi.nlm.nih.gov/pubmed/36786935
http://dx.doi.org/10.1007/s40120-023-00442-3

Ejemplares similares